For the quarter ending 2026-03-31, MYO made $10,113,288 in revenue. -$3,009,399 in net income. Net profit margin of -29.76%.
| Income Statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Revenue | 10,113,288 | 11,353,295 | 10,090,699 | 9,652,234 |
| Cost of revenue | 3,211,682 | 3,569,022 | 3,648,451 | 3,600,061 |
| Gross profit | 6,901,606 | 7,784,273 | 6,442,248 | 6,052,173 |
| Research and development | 1,623,160 | 1,624,823 | 1,527,660 | 2,001,331 |
| Selling, clinical and marketing | 4,816,759 | 5,501,163 | 5,254,246 | 5,233,885 |
| General and administrative | 3,618,739 | 3,432,046 | 3,177,856 | 3,407,277 |
| Total operating expenses | 10,058,658 | 10,558,032 | 9,959,762 | 10,642,493 |
| Loss from operations | -3,157,052 | -2,773,759 | -3,517,514 | -4,590,320 |
| Interest expense (income), net | -504,696 | -739,629 | -9,743 | 106,549 |
| Change in fair value of derivative liabilities | 839,064 | -216,673 | - | - |
| Total other expense (income), net | 334,368 | -956,302 | -9,743 | 106,549 |
| Loss before income taxes | -2,822,684 | -3,730,061 | -3,527,257 | -4,483,771 |
| Income tax expense | 186,715 | 83,878 | 135,658 | 148,201 |
| Net loss | -3,009,399 | -3,813,939 | -3,662,915 | -4,631,972 |
| Basic EPS | -0.07 | -0.09 | -0.09 | -0.11 |
| Diluted EPS | -0.07 | -0.09 | -0.09 | -0.11 |
| Basic Average Shares | 42,269,133 | 42,217,099 | 42,168,120 | 41,582,737 |
| Diluted Average Shares | 42,269,133 | 42,217,099 | 42,168,120 | 41,582,737 |
MYOMO, INC. (MYO)
MYOMO, INC. (MYO)